Beow Y. Yeap

Harvard University — United States

Medicine · Health Sciences

85h-index25.2kcitations446works1.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Treatments and Mutations(141), Lung Cancer Research Studies(94), Occupational and environmental lung diseases(74), Medical Imaging and Pathology Studies(57), Cancer Genomics and Diagnostics(40)

Publications446 total

Prospective, randomized dose-escalation trial with proton-based radiation for skull base and cervical spine chondrosarcomas: 30-year outcomes from PROG 85-26
Neuro-Oncology·2025
PROTON THERAPY PRESERVES COGNITIVE FUNCTION AND QUALITY OF LIFE IN PATIENTS WITH LOWER GRADE GLIOMAS: A PHASE II STUDY
International Journal of Particle Therapy·2025Open Access
PATTERNS OF RECURRENCE AFTER SURGERY AND PROTON-BASED RADIOTHERAPY FOR SKULL BASE AND C-SPINE CHORDOMAS: A SECONDARY ANALYSIS FROM PROG 85-26
International Journal of Particle Therapy·2025Open Access
Efficacy and Safety of Continuing Next-Generation ALK TKIs With Chemotherapy for Advanced ALK-Positive NSCLC: A Multicenter Retrospective Study
Journal of the National Comprehensive Cancer Network·2025
Establishing Albumin-Bilirubin Score Changes as Predictors of Radiation-Induced Liver Disease in Hepatocellular Carcinoma Patients Post–External Beam Radiation Therapy
International Journal of Radiation Oncology*Biology*Physics·2025
Multiomic, Histologic, and scRNA-seq Profiling of Pleural Mesothelioma Reveals Negative Prognosis Associated With a Novel Uncommitted Molecular Phenotype
Journal of Thoracic Oncology·2025· 1 citedOpen Access
RADT-85. PHASE II STUDY OF PROTON THERAPY FOR LOWER GRADE GLIOMAS: SURVIVAL AND TOXICITY OUTCOMES
Neuro-Oncology·2025Open Access
Immune Composition and Immunotherapy Outcomes of Mesothelioma With BAP1, CDKN2A, MTAP, and NF2 Alterations
Journal of Thoracic Oncology·2025· 4 cited
Predictive Model of Acute Rectal Toxicity in Prostate Cancer Treated With Radiotherapy
JCO Clinical Cancer Informatics·2025
Phase II study of neoadjuvant NALIRIFOX followed by chemoradiation with paclitaxel and carboplatin in locally advanced gastroesophageal cancer.
Journal of Clinical Oncology·2025
Long-term Outcomes of Definitive Chemoradiation With Proton Therapy for Treatment of Carcinoma of the Anal Canal: Combined Analysis of Two Prospective Trials
International Journal of Radiation Oncology*Biology*Physics·2025· 1 cited
Data from Phase I/II Investigator-Initiated Study of Olaparib and Temozolomide in SCLC: Final Analysis and CNS Outcomes
2025Open Access
Supplemental Figure 2 from Phase I/II Investigator-Initiated Study of Olaparib and Temozolomide in SCLC: Final Analysis and CNS Outcomes
2025Open Access
Supplemental Table 2 from Phase I/II Investigator-Initiated Study of Olaparib and Temozolomide in SCLC: Final Analysis and CNS Outcomes
2025Open Access
Supplemental Table 1 from Phase I/II Investigator-Initiated Study of Olaparib and Temozolomide in SCLC: Final Analysis and CNS Outcomes
2025Open Access
Supplemental Figure 1 from Phase I/II Investigator-Initiated Study of Olaparib and Temozolomide in SCLC: Final Analysis and CNS Outcomes
2025Open Access
Supplemental Figure 3 from Phase I/II Investigator-Initiated Study of Olaparib and Temozolomide in SCLC: Final Analysis and CNS Outcomes
2025Open Access
Supplemental Data 1 from Phase I/II Investigator-Initiated Study of Olaparib and Temozolomide in SCLC: Final Analysis and CNS Outcomes
2025Open Access
Phase 2 Trial of Consolidative Stereotactic Body Radiation Therapy in Patients With Metastatic Oncogene-driven Non-small Cell Lung Carcinoma Treated With Tyrosine Kinase Inhibitors
International Journal of Radiation Oncology*Biology*Physics·2024· 3 cited
Phase I/II Investigator-Initiated Study of Olaparib and Temozolomide in SCLC: Final Analysis and CNS Outcomes
Clinical Cancer Research·2024· 2 cited
page 1 of 23Next →

Frequent Co-authors

Pasi A. Jänne(14), Bruce E. Johnson(12), Alice T. Shaw(11), A. John Iafrate(8), Justin F. Gainor(8), Jeffrey A. Engelman(8), Mari Mino–Kenudson(7), David M. Jackman(7), Thomas F. DeLaney(7), Lecia V. Sequist(6), Aaron N. Hata(6), Neal I. Lindeman(6), Jeffrey W. Clark(6), Daniel B. Costa(5), Lucian R. Chirieac(5), Eunice L. Kwak(5), Thomas J. Lynch(5), Jennifer Y. Wo(5), David P. Ryan(5), Lawrence S. Blaszkowsky(5)